Dr. Wu is an Associate Professor in the Department of Medicine/Cardiology at the University of Chicago. She earned her bachelor's and master’s degrees in medicine in China, where she also completed her residency in Cardiology and Infectious Diseases. She then moved to Germany, earning her M.D. and Ph.D. in Molecular Cell Biology. Her postdoctoral training was conducted in Dr. Hossein Ardehali's laboratory at Northwestern University, supported by an American Heart Association (AHA) fellowship and an AHA Scientist Development Grant Award. Since joining the University of Chicago faculty, she has received funding from Pilot and Feasibility (P&F) grants from Chicago DRTC through NIH, several ITM grants, and an NIH RO1. Dr. Wu has contributed significantly to basic cardiovascular disease research, with nearly 40 publications to her name. Some of her work has been featured in leading medical journals, such as Circulation Research, JCI, EMBO Molecular Medicine, Nature Communications, and Oxid Med Cell Longev. Her groundbreaking work identified ARNT as a novel regulator of cardiac metabolism, established a link between ARNT and impaired angiogenesis in diabetes, and discovered a new function of MMP3 in the blood–brain barrier. Her current research focuses on how cardiac microvascular function adapts to pathophysiological stresses, such as sepsis, cardiac ischemia–reperfusion injury, and diabetes.